Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Fuchs

Showing results (231-240 of 257) with videos related to

Pageof 26
Sort By:
Journal of Clinical Microbiology|November 1, 1992
Interpretive criteria and quality control parameters for testing susceptibility of Haemophilus influenzae to enoxacin, ofloxacin, and temafloxacinA L Barry, J H Jorgensen, D J Hardy, et al.
Diagnostic Microbiology and Infectious Disease|January 1, 1988
Effect of clavulanic acid on the susceptibility of clinical anaerobic bacteria to ticarcillin: a multicenter studyP C Fuchs, R N Jones, A L Barry, et al.
European Journal of Epidemiology|November 1, 1993
In vitro activity of ceftriaxone and other cephalosporins against 602 clinical isolates of staphylococci from geographically diverse medical centersM A Pfaller, A L Barry, L D Sabath, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1988
In vitro activity of FCE 22101, imipenem, and ceftazidime against over 6,000 bacterial isolates and MIC quality control limits of FCE 22101A L Barry, K E Aldridge, S D Allen, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|August 2, 2012
[Extensive fibromata pendulantia. Hydrosurgery as a therapy option using the Versajet technique]A Bozkurt, P C Fuchs, E Dunda, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1989
Multicenter in vitro evaluation of SM-7338, a new carbapenemR N Jones, K E Aldridge, S D Allen, et al.
Diagnostic Microbiology and Infectious Disease|August 1, 1988
Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testingR N Jones, K E Aldridge, A L Barry, et al.
Journal of Clinical Microbiology|March 1, 1993
Susceptibility of Haemophilus influenzae to piperacillin-tazobactam combinations: interpretive criteria and quality control limits for standardized testsA L Barry, P C Fuchs, J H Jorgensen, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1994
Comparison of identification systems for Staphylococcus epidermidis and other coagulase-negative Staphylococcus speciesT M Perl, P R Rhomberg, M J Bale, et al.
Journal of Clinical Microbiology|July 1, 1986
Selection of a reference lot of Mueller-Hinton agarH M Pollock, A L Barry, T L Gavan, et al.
Pageof 26

Showing results (231-240 of 257) with videos related to

Sort By:
Pageof 26
Journal of Clinical Microbiology|November 1, 1992
Interpretive criteria and quality control parameters for testing susceptibility of Haemophilus influenzae to enoxacin, ofloxacin, and temafloxacinA L Barry, J H Jorgensen, D J Hardy, et al.
Diagnostic Microbiology and Infectious Disease|January 1, 1988
Effect of clavulanic acid on the susceptibility of clinical anaerobic bacteria to ticarcillin: a multicenter studyP C Fuchs, R N Jones, A L Barry, et al.
European Journal of Epidemiology|November 1, 1993
In vitro activity of ceftriaxone and other cephalosporins against 602 clinical isolates of staphylococci from geographically diverse medical centersM A Pfaller, A L Barry, L D Sabath, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1988
In vitro activity of FCE 22101, imipenem, and ceftazidime against over 6,000 bacterial isolates and MIC quality control limits of FCE 22101A L Barry, K E Aldridge, S D Allen, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|August 2, 2012
[Extensive fibromata pendulantia. Hydrosurgery as a therapy option using the Versajet technique]A Bozkurt, P C Fuchs, E Dunda, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1989
Multicenter in vitro evaluation of SM-7338, a new carbapenemR N Jones, K E Aldridge, S D Allen, et al.
Diagnostic Microbiology and Infectious Disease|August 1, 1988
Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testingR N Jones, K E Aldridge, A L Barry, et al.
Journal of Clinical Microbiology|March 1, 1993
Susceptibility of Haemophilus influenzae to piperacillin-tazobactam combinations: interpretive criteria and quality control limits for standardized testsA L Barry, P C Fuchs, J H Jorgensen, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1994
Comparison of identification systems for Staphylococcus epidermidis and other coagulase-negative Staphylococcus speciesT M Perl, P R Rhomberg, M J Bale, et al.
Journal of Clinical Microbiology|July 1, 1986
Selection of a reference lot of Mueller-Hinton agarH M Pollock, A L Barry, T L Gavan, et al.
Pageof 26